The purine nucleoside adenosine in retinal ischemia-reperfusion injury

Vision Research

Volumn 39, Issue 15, 1999, Pages 2519-2535

  Ghiardi, Greg J ^a   Gidday, Jeffrey M ^b   Roth, Steven ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b Ophthalmol Vis Sci Cell Biol P   (United States)

Author keywords

Adenosine; Ischemia reperfusion injury; Oxygen delivery; Retina

Indexed keywords

ADENOSINE DERIVATIVE; VASCULOTROPIN;

ARTICLE; DRUG EFFECT; NONHUMAN; PHOSPHATE METABOLISM; PRIORITY JOURNAL; REPERFUSION INJURY; RETINA BLOOD FLOW; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION;

ADENOSINE; ANIMALS; CATTLE; CLONING, MOLECULAR; DIABETIC RETINOPATHY; GENE EXPRESSION; GUINEA PIGS; HUMANS; ISCHEMIA; ISCHEMIC PRECONDITIONING; RATS; RECEPTORS, PURINERGIC P1; REPERFUSION INJURY; RETINA; RETINAL VESSELS;

EID: 0032918526     PISSN: 00426989     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6989(99)00038-3     Document Type: Article

References (91)

1. Aiello L.P., Pierce E.A., Foley E.D., Takagi H., Chen H., Riddle L., Ferrara N., King G.L., Smith L.E.H. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proceedings of the National Academy of Sciences USA. 92:1995;10457-10461.
2. Alder V.A., Su E.N., Yu D.Y., Cringle S.J., Yu P.K. Asymmetrical response of the intraluminal and extraluminal surfaces of the porcine retinal artery to exogenous adenosine. Experimental Eye Research. 63:1996;557-564.
3. 2-dependent type. Amino acid sequence of rat liver xanthine dehydrogenase and identification of the cleavage sites of the enzyme protein during irreversible conversion by trypsin. Journal of Biological Chemistry. 265:1990;14170-14175.
4. Asaoka Y., Nakamura S., Yoshida K., Nishizuka Y. Protein kinase C, calcium and phospholipid degradation. Trends in Biochemical Sciences. 17:1992;414-417.
5. Atkins P.T., Liu P.K., Hsu C.Y. Immediate early gene expression in response to cerebral ischemia. Friend or foe? Stroke. 27:1996;1682-1687.
6. Augustin A.J., Boker T., Blumenroder S.H., Lutz J., Spitznas M. Free radical scavenging and antioxidant activity of allopurinol and oxypurinol in experimental lens-induced uveitis. Investigative Ophthalmology and Visual Science. 35:1994;3897-3904.
7. Berne R.M., Rubio R., Curnish R.R. Release of adenosine from ischemic brain: effect on cerebral vascular resistance and incorporation into cerebral adenine nucleotides. Circulation Research. 35:1974;262-271.
8. Blazynski C., Mosinger J.L., Cohen A.I. Comparison of adenosine uptake and endogenous adenosine-containing cells in mammalian retina. Visual Neuroscience. 2:1989a;109-116.
9. Blazynski C., Cohen A.I., Fruh B., Niemeyer G. Adenosine: autoradiographic localization and electrophysiologic effects in the cat retina. Investigative Ophthalmology and Visual Science. 30:1989b;2533-2536.
10. 3H]adenosine into rabbit retinal neurons is inhibited by nitrobenzylthioinosine (NBI). Neuroscience Letters. 121:1991;1-4.
11. Blazynski C., Perez M.T. Adenosine in vertebrate retina: localization, receptor characterization, and function. Cellular and Molecular Neurobiology. 11:1991;463-484.
12. Blazynski C., McIntosh H. Characterization of adenosine A2 receptors in bovine retinal membranes. Experimental Eye Research. 56:1992;585-593.
13. Braas K.M., Zarbin M.A., Snyder S.H. Endogenous adenosine and adenosine receptors localized to ganglion cells of the retina. Proceedings of the National Academy of Sciences USA. 84:1987;3906-3910.
14. Braunagel S.C., Xaio J.G., Chiou G.C. The potential role of adenosine in regulating blood flow in the eye. Journal of Ocular Pharmacology. 4:1988;61-73.
15. Campochiaro P.A., Sen H.A. Adenosine and its agonists cause retinal vasodilation and hemorrhage. Implications for ischemic retinopathies. Archives of Ophthalmology. 107:1989;412-416.
16. Chen Q., Harris C., Brown C.S., Howe A., Surmeier D.J., Reiner A. Glutamatemediated excitotoxic death of cultured striatal neurons is mediated by non-NMDA receptors. Experimental Neurology. 136:1995;212-224.
17. Choi D.W. Calcium: still canter-stage in hypoxic-ischemic neuronal death. Trends in Neurosciences. 18:1995;58-60.
18. Cronstein B. Adenosine, an endogenous anti-inflammatory agent. Journal of Applied Physiology. 76:1994;5-13.
19. Crosson C., DeBenedetto R., Gidday J.M. Functional evidence for retinal adenosine receptors. Journal of Ocular Pharmacology. 10:1994;499-507.
20. Deussen A., Lloyd H.G., Schrader J. Contribution of S-adenosylhomocysteine to cardiac adenosine formation. Journal of Molecular and Cellular Cardiology. 21:1989;773-782.
21. Dreyer E.B., Zurakowski D., Schumer R.A., Podos S.M., Lipton S.A. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Archives of Ophthalmology. 114:1996;299-305.
22. Fredholm B.B. Analysis of purines. Life Science. 41:1987;837-840.
23. Friedman Z., Hackett S.F., Linden J., Campochiaro P.A. Human retinal pigment epithelial cells in culture posses A2-adenosine receptors. Brain Research. 492:1989;29-35.
24. Geiger J.D., Padua R.A., Nagy J.I. Adenosine deaminase regulation of purine actions. Phillis J.W. Adenosine and adenine nucleotides as regulators of cellular function. 1991;71-84 CRC, Boca Raton, FL.
25. Geiger J.D., Parkinson F.E., Kowaluk E.W. Regulators of endogenous adenosine levels as therapeutic agents. Jacobson K.A., Jarvis M.F. Purinergic approaches in experimental therapeutics. 1997;55-84 Wiley-Liss, New York.
26. Gidday J.M., Park T.S. Adenosine-mediated autoregulation of retinal arteriolar tone in the piglet. Investigative Ophthalmology and Visual Science. 34:1993a;2713-2719.
27. Gidday J.M., Park T.S. Microcirculatory responses to adenosine in the newborn pig retina. Pediatric Research. 33:1993b;620-627.
28. ATP channels mediate adenosine-induced hyperemia in retina. Investigative Ophthalmology and Visual Science. 37:1996;2624-2633.
29. Gidday J.M., Zhu Y. Endothelium-dependent changes in retinal blood flow following ischemia. Current Eye Research. 17:1998;798-807.
30. Hayashi A., Koroma B.M., Imai K., de Juan Jr. E. Increase of protein tyrosine phosphorylation in rat retina after ischemia-reperfusion injury. Investigative Ophthalmology and Visual Science. 37:1996;2146-2156.
31. Headrick J.P., Bendall M.R., Faden A.I., Vink R. Dissociation of adenosine levels from bioenergetic state in experimental brain trauma: potential role in secondary injury. Journal of Cerebral Blood Flow and Metabolism. 14:1994;853-861.
32. Jacobson K.A., Galen P.J.V., Williams M. Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. Journal of Medicinal Chemistry. 35:1992;407-422.
33. Jacobson K.A. Adenosine A3 receptors: novel ligands and paradoxical effects. Trends in Pharmacological Sciences. 19:1998;184-191.
34. Koistinaho J., Hokfelt T. Altered gene expression in brain ischemia. NeuroReport. 8:1997;2-7.
35. Kontny E., Kvanta A., Fredholm B.B. Activation of protein kinase C and elevation of cAMP interact synergistically to raise c-Fos and AP-1 activity in Jurkat cells. European Journal of Pharmacology. 227:1992;333-338.
36. Kostic M.M., Schrader J. Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circulation Research. 70:1992;208-212.
37. Kvanta A., Fredholm B.B. Synergistic effects between protein kinase C and cAMP on activator protein-1 activity and differentiation of PC-12 pheochromocytoma cells. Journal of Molecular Neuroscience. 4:1993;205-214.
38. Kvanta A., Seregard S., Sejersen S., Kull B., Fredholm B.B. Localization of adenosine receptor messenger RNAs in the rat eye. Experimental Eye Research. 65:1997;595-602.
39. Larsen A.K., Osborne N.N. Involvement of adenosine in retinal ischemia: studies in the rat. Investigative Ophthalmology and Visual Science. 37:1996;2603-2611.
40. Latini S., Corsi C., Pedata F., Pepeu G. The source of brain adenosine outflow during ischemia and electrical stimulation. Neurochemical International. 28:1996;113-118.
41. Lee K.S., Tetzlaff W., Kreutzberg G.W. Rapid down regulation of hippocampal adenosine receptors following brief anoxia. Brain Research. 380:1986;155-158.
42. Li B., Rosenbaum P. S., Jennings N. M., Maxwell K. A., Roth S. Differential roles of adenosine receptor subtypes in retinal ischemia-reperfusion injury in the rat. Experimental Eye Research. 68:1999;9-17.
43. Li, B., & Roth, S. (in press). Retinal ischemic preconditioning protection requires adenosine and may be repeatedly induced. Investigative Ophthalmology and Visual Science.
44. Lin J., Roth S. Retinal hypoperfusion following ischemia in rats depends upon the duration of ischemia (abstract). Investigative Ophthalmology and Visual Science (supplement). 39:1998;1238.
45. Linden J. Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions. Trends in Pharmacological Sciences. 15:1994;298-306.
46. Linden J., Taylor H.E., Robeva A.S., Tucker A.L., Stehle J.H., Rivkees S.A., Fink J.S., Reppert S.M. Molecular cloning and functional expression of sheep A3 adenosine receptor with widespread tissue distribution. Molecular Pharmacology. 44:1993;524-532.
47. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. New England Journal of Medicine. 330:1994;613-622.
48. Lofti K., Grunwald J.E. The effect of caffeine on the human macular circulation. Investigative Ophthalmology and Visual Science. 32:1991;3028-3032.
49. Louzada Jr. P., Dias J.J., Santos W.F., Lachat J.J., Bradford H.F., Coutinho-Netto J. Glutamate release in experimental ischaemia of the retina: an approach using rnicrodialysis. Journal of Neurochemistry. 59:1992;358-363.
50. Lutty G. A., Mathews M. K., Merges C., McLeod D.S. Adenosine stimulates canine retinal microvascular endothelial cell migration and tube formation. Current Eye Research. 17:1998;594-607.
51. Matsugi T., Chen Q., Anderson D.R. Adenosine-induced relaxation of cultured bovine retinal pericytes. Investigative Ophthalmology and Visual Science. 38:1997;2695-2701.
52. Miller J.W., Adamis A.P., Aiello L.P. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes/Metabolism Reviews. 13:1997;37-50.
53. Mosinger J.L., Price M.T., Bai H.Y., Xiao H., Wozniak D.F., Olney J.W. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina. Experimental Neurology. 113:1991;10-17.
54. 3H]-glycogen hydrolysis elicited by adenosine in rabbit retina: Involvement of A2 receptors. Neurochemistry International. 14:1989;419-422.
55. Ostwald P., Park S.S., Toledano A.Y., Roth S. Adenosine receptor blockade and nitric oxide synthase inhibition: impact upon blood flow and the electroretinogram following retinal ischemia. Vision Research. 37:1997;3453-3461.
56. Peachey N.S., Green D.J., Ripps H. Ocular ischemia and the effects of allopurinol on functional recovery in the retina of the arterially perfused cat eye. Investigative Ophthalmology and Visual Science. 34:1993;58-65.
57. Perez M.T., Ehinger B.E., Lindstrom K., Fredholm B.B. Release of endogenous and radioactive purines from the rabbit retina. Brain Research. 398:1986;106-112.
58. Perez-Pinzon M.A., Lutz P.L., Sick T.J., Rosenthal M. Adenosine, a retaliatory metabolise, promotes anoxia tolerance in turtle brain. Journal of Cerebral Blood Flow and Metabolism. 13:1993;728-732.
59. Phillis J.W. Adenosine in the control of the cerebral circulation. Cerebrovascular and Brain Metabolism Reviews. 1:1989;26-54.
60. Phillis J.W. The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil. Brain Research. 705:1995;79-84.
61. Phillis J.W., O'Regan M.H. Effects of an inhibitor of adenosine deaminase, deoxycoformycin, and of nucleoside transport, propentofylline, on post-ischemic recovery of adenine nucleotides in rat brain. Neurochemical Research. 21:1996;347-353.
62. Phillis J.W., Smith-Barbour M. The adenosine kinase inhibitor, 5-iodotubercidin, is not protective against cerebral ischemic injury in the gerbil. Life Science. 53:1993;497-502.
63. Phillis J.W., Smith-Barbour M., O'Regan M.H., Perkins L.M. Amino acid and purine release in rat brain following temporary middle cerebral artery occlusion. Neurochemical Research. 19:1994;1125-1130.
64. Portellos M., Riva C.E., Cranstoun S.D., Petrig B.L., Brucker A.J. Effects of adenosine on ocular blood flow. Investigative Ophthalmology and Visual Science. 36:1995;1904-1909.
65. Poss W.B., Huecksteadt T.P., Panus P.C., Freeman B.A., Hoidal J.R. Regulation of xanthine dehydrogenase and xanthine oxidase activity by hypoxia. American Journal of Physiology. 270:1996;L941-L946.
66. Rehncrona S., Siesjo B.K., Westerberg E. Adenosine and cyclic AMP in cerebral cortex of rats in hypoxia, status epilepticus and hypercapnia. Acta Physiologica Scandanavica. 104:1978;453-463.
67. Roth S. Post-ischemic hyperemia in the retina: the effects of adenosine receptor blockade. Current Eye Research. 14:1995;323-328.
68. Roth S., Li B., Rosenbaum P.S., Gupta H., Goldstein I.M., Maxwell K.M., Gidday J.M. Preconditioning completely prevents injury after retinal ischemia in rats. Investigative Ophthalmology and Visual Science. 39:1998;775-785.
69. Roth S., Osinski J., Park S.S., Ostwald P., Moshfeghi A.A. Measurement of purine nucleoside concentration in the intact rat retina. Journal of Neuroscience Methods. 68:1996;87-90.
70. Roth S., Park S.S., Sikorski C., Osinski J., Chan R. Purine nucleoside concentration during reperfusion following retinal ischemia in rats. Current Eye Research. 16:1997a;875-885.
71. Roth S., Pietrzyk Z. Blood flow after retinal ischemia in cats. Investigative Ophthalmology and Visual Science. 35:1994;3209-3217.
72. Roth S., Rosenbaum P.S., Osinski J., Park S.S., Toledano A.Y., Li B., Moshfeghi A.A. Ischemia induces significant changes in purine concentration in the retina-choroid in rats. Experimental Eye Research. 65:1997b;771-779.
73. Rudolphi K.A., Schubert P. Modulation of neuronal and glial cell function by adenosine and neuroprotection in vascular dementia. Behavioral and Brain Research. 83:1997;123-128.
74. Schubert P., Rudolphi K.A., Fredholm B.B., Nakamura Y. Modulation of nerve and glial function by adenosine - role in the development of ischemic damage. International Journal of Biochemistry. 26:1994;1227-1236.
75. Sciotti V.M., van Wylen D.G. Increases in interstitial adenosine and cerebral blood flow with inhibition of adenosine kinase and adenosine dearninase. Journal of Cerebral Blood Flow and Metabolism. 13:1993;201-207.
76. Sebastiao A.M., Ribeiro J.A. Adenosine A2 receptor-mediated excitatory actions on the nervous system. Progress in Neurobiology. 48:1996;167-189.
77. Sen H.A., Campochiaro P.A. Intravitreous injection of adenosine or its agonists causes breakdown of the blood-retinal barrier. Archives of Ophthalmology. 107:1989;1364-1367.
78. Smolenski R.T., Kochan Z., McDouall R., Page C., Seymour A.-M.L., Yacoub M.H. Endothelial nucleotide catabolism and adenosine production. Cardiovascular Research. 28:1994;100-104.
79. Spychala J., Datta N.S., Takabayashi K., Datta M., Fox I.H., Gribbin T., Mitchell B.S. Cloning of human adenosine kinase cDNA: Sequence similarity to microbial ribokinases and fructokinases. Proceedings of the National Academy of Sciences USA. 93:1996;1232-1237.
80. Stiles G.L. Adenosine receptor subtypes: new insights from cloning and functional studies. Jacobson K.A., Jarvis M.F. Purinergic approaches in experimental therapeutics. 1997;Wiley-Liss, New York.
81. Takagi H., King G.L., Ferrara N., Aiello L.P. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Investigative Ophthalmology and Visual Science. 37:1996a;1311-1321.
82. Takagi H., King G.L., Robinson G.S., Ferrara N., Aiello L.P. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Investigative Ophthalmology and Visual Science. 37:1996b;2165-2176.
83. Terada L.S., Guidot D.M., Leff J.A., Willingham I.R., Hanley M.E., Piermattei D., Repine J.E. Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity. Proceedings of the National Academy of Sciences USA. 89:1992;3362-3366.
84. Terada L.S., Willingham I.R., Rosandich M.E., Leff J.A., Kindt G.W., Repine J.E. Generation of superoxide anion by brain endothelial cell xanthine oxidase. Journal of Cellular Physiology. 148:1991;191-196.
85. von Lubitz D.K., Carter M.F., Beenhakker M., Lin R.C., Jacobson K.A. Adenosine: a protherapeutic concept in neurodegeneration. Trembly B. Neuroprotective agents: experimental and clinical perspectives. 1995;160-178 NY Academy of Sciences, New York.
86. Williams M., Burnstock G. Purinergic neurotransmission and neuromodulation: a historical perspective. Jacobson K.A., Jarvis M.F. Purinergic approaches in experimental therapeutics. 1997;3-26 Wiley-Liss, New York.
87. Winn H.R., Rubio R., Berne R.M. Brain adenosine concentration during hypoxia in rats. American Journal of Physiology. 241:1981;H235-H242.
88. Yoon Y., Marmor M. Dextromethorphan protects retina against ischemic injury in vivo. Archives of Ophthalmology. 107:1989;409-411.
89. Zeevalk G.D., Nicklas W.J. Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina. Journal of Pharmacology and Experimental Therapeutics. 253:1990;1285-1292.
90. Zhang G., Franklin P.H., Murray T.F. Manipulation of endogenous adenosine in the rat prepiriform cortex modulates seizure susceptibility. Journal of Pharmacology and Experimental Therapeutics. 264:1993;1415-1424.
91. Zhu Y., Gidday J.M. Hypoglycemic hyperemia in retina of newborn pigs. Involvement of adenosine. Investigative Ophthalmology and Visual Science. 37:1996;86-92.